WallStreetZenWallStreetZen

NASDAQ: MDRX
Veradigm Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for MDRX

Based on 7 analysts offering 12 month price targets for Veradigm Inc.
Min Forecast
$17.00-1.73%
Avg Forecast
$22.07+27.58%
Max Forecast
$26.00+50.29%

Should I buy or sell MDRX stock?

Based on 8 analysts offering ratings for Veradigm Inc.
Buy
Strong Buy
3 analysts 37.5%
Buy
1 analysts 12.5%
Hold
3 analysts 37.5%
Sell
0 analysts 0%
Strong Sell
1 analysts 12.5%

Be the first to know when Wall Street analysts revise their MDRX stock forecasts and price targets.

MDRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Piper Sandler
Top 24%
77
HoldDowngrades$18.50+6.94%2023-02-01
Argus Research
Top 12%
89
Strong BuyUpgrades$26.00+50.29%2022-12-07
JP Morgan
Top 34%
67
Strong SellMaintains$20.00+15.61%2022-11-18
Goldman Sachs
Top 37%
64
Strong BuyUpgrades$23.00+32.95%2022-11-09
KeyBanc
Top 23%
78
HoldInitiates Coverage OnN/AN/A2022-09-16
Piper Sandler
Bottom 6%
6
HoldMaintains$17.00-1.73%2022-06-10
Deutsche Bank
Top 15%
86
Strong BuyUpgrades$26.00+50.29%2022-03-04Find out why
SVB Leerink
Bottom 3%
3
BuyMaintains$24.00+38.73%2022-03-03

1 of 1

Forecast return on equity

Is MDRX forecast to generate an efficient return?
Company
6.22%
Industry
7.18%
Market
47.94%
MDRX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MDRX forecast to generate an efficient return on assets?
Company
4.33%
Industry
4.85%
MDRX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MDRX earnings per share forecast

What is MDRX's earnings per share in the next 2 years based on estimates from 3 analysts?
Avg 1 year Forecast
$0.73+62.22%
Avg 2 year Forecast
$0.67+48.89%
MDRX's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

MDRX revenue forecast

What is MDRX's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$657.3M-21.49%
Avg 2 year Forecast
$704.8M-15.81%
MDRX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

MDRX earnings growth forecast

How is MDRX forecast to perform vs Health Information Services companies and vs the US market?
Company
62.22%
Industry
46.52%
Market
85.06%
MDRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
MDRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
MDRX's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

MDRX revenue growth forecast

How is MDRX forecast to perform vs Health Information Services companies and vs the US market?
Company
-21.49%
Industry
23.34%
Market
70.6%
MDRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
MDRX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

MDRX vs Health Information Service Stocks

TickerPricePrice TargetUp/downsideConsensus
MDRX$17.30$22.07+27.58%Buy
SDGR$26.13$64.75+147.80%Strong Buy
PHR$37.87$36.50-3.62%Strong Buy
DH$13.12$21.25+61.97%Buy
GDRX$5.77$9.92+71.94%Buy
View Top Health Information Service Stocks

Veradigm Stock Forecast FAQ

Is Veradigm Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: MDRX) stock is to Buy MDRX stock.

Out of 8 analysts, 3 (37.5%) are recommending MDRX as a Strong Buy, 1 (12.5%) are recommending MDRX as a Buy, 3 (37.5%) are recommending MDRX as a Hold, 0 (0%) are recommending MDRX as a Sell, and 1 (12.5%) are recommending MDRX as a Strong Sell.

If you're new to stock investing, here's how to buy Veradigm stock.

What is MDRX's earnings growth forecast for 2023-2024?

(NASDAQ: MDRX) Veradigm's forecast annual earnings growth rate of 62.22% is forecast to beat the US Health Information Services industry's average forecast earnings growth rate of 46.52%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 85.06%.

Veradigm's earnings in 2023 is $60,634,000.On average, 3 Wall Street analysts forecast MDRX's earnings for 2023 to be $79,759,636, with the lowest MDRX earnings forecast at $55,722,486, and the highest MDRX earnings forecast at $102,704,189.

In 2024, MDRX is forecast to generate $73,204,050 in earnings, with the lowest earnings forecast at $73,204,050 and the highest earnings forecast at $73,204,050.

What is MDRX's revenue growth forecast for 2023-2024?

(NASDAQ: MDRX) Veradigm's forecast annual revenue growth rate of -21.49% is not forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 23.34%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 70.6%.

Veradigm's revenue in 2023 is $837,191,000.On average, 1 Wall Street analysts forecast MDRX's revenue for 2023 to be $71,816,450,765, with the lowest MDRX revenue forecast at $71,816,450,765, and the highest MDRX revenue forecast at $71,816,450,765.

In 2024, MDRX is forecast to generate $77,006,290,125 in revenue, with the lowest revenue forecast at $77,006,290,125 and the highest revenue forecast at $77,006,290,125.

What is MDRX's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: MDRX) forecast ROA is 4.33%, which is lower than the forecast US Health Information Services industry average of 4.85%.

What is MDRX's Price Target?

According to 7 Wall Street analysts that have issued a 1 year MDRX price target, the average MDRX price target is $22.07, with the highest MDRX stock price forecast at $26.00 and the lowest MDRX stock price forecast at $17.00.

On average, Wall Street analysts predict that Veradigm's share price could reach $22.07 by Feb 1, 2024. The average Veradigm stock price prediction forecasts a potential upside of 27.58% from the current MDRX share price of $17.30.

What is MDRX's Earnings Per Share (EPS) forecast for 2023-2024?

(NASDAQ: MDRX) Veradigm's current Earnings Per Share (EPS) is $0.45. On average, analysts forecast that MDRX's EPS will be $0.73 for 2023, with the lowest EPS forecast at $0.51, and the highest EPS forecast at $0.94. In 2024, MDRX's EPS is forecast to hit $0.67 (min: $0.67, max: $0.67).

What is MDRX's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: MDRX) forecast ROE is 6.22%, which is considered weak.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.